1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Biologics
        1.2.3 Small Molecules
    1.3 Market by Application
        1.3.1 Global Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Small Cell Lung Cancer Therapeutics Market Perspective (2017-2028)
    2.2 Small Cell Lung Cancer Therapeutics Growth Trends by Region
        2.2.1 Small Cell Lung Cancer Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Small Cell Lung Cancer Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Small Cell Lung Cancer Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Small Cell Lung Cancer Therapeutics Market Dynamics
        2.3.1 Small Cell Lung Cancer Therapeutics Industry Trends
        2.3.2 Small Cell Lung Cancer Therapeutics Market Drivers
        2.3.3 Small Cell Lung Cancer Therapeutics Market Challenges
        2.3.4 Small Cell Lung Cancer Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Small Cell Lung Cancer Therapeutics Players by Revenue
        3.1.1 Global Top Small Cell Lung Cancer Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Small Cell Lung Cancer Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Small Cell Lung Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Small Cell Lung Cancer Therapeutics Revenue
    3.4 Global Small Cell Lung Cancer Therapeutics Market Concentration Ratio
        3.4.1 Global Small Cell Lung Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Small Cell Lung Cancer Therapeutics Revenue in 2021
    3.5 Small Cell Lung Cancer Therapeutics Key Players Head office and Area Served
    3.6 Key Players Small Cell Lung Cancer Therapeutics Product Solution and Service
    3.7 Date of Enter into Small Cell Lung Cancer Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Small Cell Lung Cancer Therapeutics Breakdown Data by Type
    4.1 Global Small Cell Lung Cancer Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Small Cell Lung Cancer Therapeutics Forecasted Market Size by Type (2023-2028)
5 Small Cell Lung Cancer Therapeutics Breakdown Data by Application
    5.1 Global Small Cell Lung Cancer Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Small Cell Lung Cancer Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Small Cell Lung Cancer Therapeutics Market Size (2017-2028)
    6.2 North America Small Cell Lung Cancer Therapeutics Market Size by Type
        6.2.1 North America Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022)
        6.2.2 North America Small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028)
        6.2.3 North America Small Cell Lung Cancer Therapeutics Market Share by Type (2017-2028)
    6.3 North America Small Cell Lung Cancer Therapeutics Market Size by Application
        6.3.1 North America Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022)
        6.3.2 North America Small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028)
        6.3.3 North America Small Cell Lung Cancer Therapeutics Market Share by Application (2017-2028)
    6.4 North America Small Cell Lung Cancer Therapeutics Market Size by Country
        6.4.1 North America Small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022)
        6.4.2 North America Small Cell Lung Cancer Therapeutics Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Small Cell Lung Cancer Therapeutics Market Size (2017-2028)
    7.2 Europe Small Cell Lung Cancer Therapeutics Market Size by Type
        7.2.1 Europe Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022)
        7.2.2 Europe Small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028)
        7.2.3 Europe Small Cell Lung Cancer Therapeutics Market Share by Type (2017-2028)
    7.3 Europe Small Cell Lung Cancer Therapeutics Market Size by Application
        7.3.1 Europe Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022)
        7.3.2 Europe Small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028)
        7.3.3 Europe Small Cell Lung Cancer Therapeutics Market Share by Application (2017-2028)
    7.4 Europe Small Cell Lung Cancer Therapeutics Market Size by Country
        7.4.1 Europe Small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022)
        7.4.2 Europe Small Cell Lung Cancer Therapeutics Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Small Cell Lung Cancer Therapeutics Market Share by Type (2017-2028)
    8.3 Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Small Cell Lung Cancer Therapeutics Market Share by Application (2017-2028)
    8.4 Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Small Cell Lung Cancer Therapeutics Market Size (2017-2028)
    9.2 Latin America Small Cell Lung Cancer Therapeutics Market Size by Type
        9.2.1 Latin America Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022)
        9.2.2 Latin America Small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028)
        9.2.3 Latin America Small Cell Lung Cancer Therapeutics Market Share by Type (2017-2028)
    9.3 Latin America Small Cell Lung Cancer Therapeutics Market Size by Application
        9.3.1 Latin America Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022)
        9.3.2 Latin America Small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028)
        9.3.3 Latin America Small Cell Lung Cancer Therapeutics Market Share by Application (2017-2028)
    9.4 Latin America Small Cell Lung Cancer Therapeutics Market Size by Country
        9.4.1 Latin America Small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022)
        9.4.2 Latin America Small Cell Lung Cancer Therapeutics Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Small Cell Lung Cancer Therapeutics Market Share by Type (2017-2028)
    10.3 Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Small Cell Lung Cancer Therapeutics Market Share by Application (2017-2028)
    10.4 Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Sanofi
        11.1.1 Sanofi Company Details
        11.1.2 Sanofi Business Overview
        11.1.3 Sanofi Small Cell Lung Cancer Therapeutics Introduction
        11.1.4 Sanofi Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022)
        11.1.5 Sanofi Recent Developments
    11.2 Bristol-Myers Squibb
        11.2.1 Bristol-Myers Squibb Company Details
        11.2.2 Bristol-Myers Squibb Business Overview
        11.2.3 Bristol-Myers Squibb Small Cell Lung Cancer Therapeutics Introduction
        11.2.4 Bristol-Myers Squibb Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022)
        11.2.5 Bristol-Myers Squibb Recent Developments
    11.3 GlaxoSmithKline
        11.3.1 GlaxoSmithKline Company Details
        11.3.2 GlaxoSmithKline Business Overview
        11.3.3 GlaxoSmithKline Small Cell Lung Cancer Therapeutics Introduction
        11.3.4 GlaxoSmithKline Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022)
        11.3.5 GlaxoSmithKline Recent Developments
    11.4 Menarini
        11.4.1 Menarini Company Details
        11.4.2 Menarini Business Overview
        11.4.3 Menarini Small Cell Lung Cancer Therapeutics Introduction
        11.4.4 Menarini Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022)
        11.4.5 Menarini Recent Developments
    11.5 Ziopharm Oncology
        11.5.1 Ziopharm Oncology Company Details
        11.5.2 Ziopharm Oncology Business Overview
        11.5.3 Ziopharm Oncology Small Cell Lung Cancer Therapeutics Introduction
        11.5.4 Ziopharm Oncology Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022)
        11.5.5 Ziopharm Oncology Recent Developments
    11.6 Merck
        11.6.1 Merck Company Details
        11.6.2 Merck Business Overview
        11.6.3 Merck Small Cell Lung Cancer Therapeutics Introduction
        11.6.4 Merck Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022)
        11.6.5 Merck Recent Developments
    11.7 Novartis
        11.7.1 Novartis Company Details
        11.7.2 Novartis Business Overview
        11.7.3 Novartis Small Cell Lung Cancer Therapeutics Introduction
        11.7.4 Novartis Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022)
        11.7.5 Novartis Recent Developments
    11.8 AstraZeneca
        11.8.1 AstraZeneca Company Details
        11.8.2 AstraZeneca Business Overview
        11.8.3 AstraZeneca Small Cell Lung Cancer Therapeutics Introduction
        11.8.4 AstraZeneca Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022)
        11.8.5 AstraZeneca Recent Developments
    11.9 Takeda Pharmaceutical
        11.9.1 Takeda Pharmaceutical Company Details
        11.9.2 Takeda Pharmaceutical Business Overview
        11.9.3 Takeda Pharmaceutical Small Cell Lung Cancer Therapeutics Introduction
        11.9.4 Takeda Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022)
        11.9.5 Takeda Pharmaceutical Recent Developments
    11.10 Teva Pharmaceutical
        11.10.1 Teva Pharmaceutical Company Details
        11.10.2 Teva Pharmaceutical Business Overview
        11.10.3 Teva Pharmaceutical Small Cell Lung Cancer Therapeutics Introduction
        11.10.4 Teva Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022)
        11.10.5 Teva Pharmaceutical Recent Developments
    11.11 Eli Lilly
        11.11.1 Eli Lilly Company Details
        11.11.2 Eli Lilly Business Overview
        11.11.3 Eli Lilly Small Cell Lung Cancer Therapeutics Introduction
        11.11.4 Eli Lilly Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022)
        11.11.5 Eli Lilly Recent Developments
    11.12 Mylan
        11.12.1 Mylan Company Details
        11.12.2 Mylan Business Overview
        11.12.3 Mylan Small Cell Lung Cancer Therapeutics Introduction
        11.12.4 Mylan Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022)
        11.12.5 Mylan Recent Developments
    11.13 Sun Pharmaceuticals Industries
        11.13.1 Sun Pharmaceuticals Industries Company Details
        11.13.2 Sun Pharmaceuticals Industries Business Overview
        11.13.3 Sun Pharmaceuticals Industries Small Cell Lung Cancer Therapeutics Introduction
        11.13.4 Sun Pharmaceuticals Industries Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022)
        11.13.5 Sun Pharmaceuticals Industries Recent Developments
    11.14 Amgen
        11.14.1 Amgen Company Details
        11.14.2 Amgen Business Overview
        11.14.3 Amgen Small Cell Lung Cancer Therapeutics Introduction
        11.14.4 Amgen Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022)
        11.14.5 Amgen Recent Developments
    11.15 Ono Pharmaceutical
        11.15.1 Ono Pharmaceutical Company Details
        11.15.2 Ono Pharmaceutical Business Overview
        11.15.3 Ono Pharmaceutical Small Cell Lung Cancer Therapeutics Introduction
        11.15.4 Ono Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022)
        11.15.5 Ono Pharmaceutical Recent Developments
    11.16 Shanghai Jinhe Bio-Technology
        11.16.1 Shanghai Jinhe Bio-Technology Company Details
        11.16.2 Shanghai Jinhe Bio-Technology Business Overview
        11.16.3 Shanghai Jinhe Bio-Technology Small Cell Lung Cancer Therapeutics Introduction
        11.16.4 Shanghai Jinhe Bio-Technology Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022)
        11.16.5 Shanghai Jinhe Bio-Technology Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Biologics
    Table 3. Key Players of Small Molecules
    Table 4. Global Small Cell Lung Cancer Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Small Cell Lung Cancer Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Small Cell Lung Cancer Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Small Cell Lung Cancer Therapeutics Market Share by Region (2017-2022)
    Table 8. Global Small Cell Lung Cancer Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Small Cell Lung Cancer Therapeutics Market Share by Region (2023-2028)
    Table 10. Small Cell Lung Cancer Therapeutics Market Trends
    Table 11. Small Cell Lung Cancer Therapeutics Market Drivers
    Table 12. Small Cell Lung Cancer Therapeutics Market Challenges
    Table 13. Small Cell Lung Cancer Therapeutics Market Restraints
    Table 14. Global Small Cell Lung Cancer Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Small Cell Lung Cancer Therapeutics Revenue Share by Players (2017-2022)
    Table 16. Global Top Small Cell Lung Cancer Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Cell Lung Cancer Therapeutics as of 2021)
    Table 17. Ranking of Global Top Small Cell Lung Cancer Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Small Cell Lung Cancer Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Small Cell Lung Cancer Therapeutics Product Solution and Service
    Table 21. Date of Enter into Small Cell Lung Cancer Therapeutics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2017-2022)
    Table 25. Global Small Cell Lung Cancer Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Small Cell Lung Cancer Therapeutics Revenue Market Share by Type (2023-2028)
    Table 27. Global Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Small Cell Lung Cancer Therapeutics Revenue Share by Application (2017-2022)
    Table 29. Global Small Cell Lung Cancer Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Small Cell Lung Cancer Therapeutics Revenue Share by Application (2023-2028)
    Table 31. North America Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Small Cell Lung Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Small Cell Lung Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Small Cell Lung Cancer Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Small Cell Lung Cancer Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Small Cell Lung Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Small Cell Lung Cancer Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Small Cell Lung Cancer Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Small Cell Lung Cancer Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Small Cell Lung Cancer Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Small Cell Lung Cancer Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Small Cell Lung Cancer Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Sanofi Company Details
    Table 62. Sanofi Business Overview
    Table 63. Sanofi Small Cell Lung Cancer Therapeutics Product
    Table 64. Sanofi Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 65. Sanofi Recent Developments
    Table 66. Bristol-Myers Squibb Company Details
    Table 67. Bristol-Myers Squibb Business Overview
    Table 68. Bristol-Myers Squibb Small Cell Lung Cancer Therapeutics Product
    Table 69. Bristol-Myers Squibb Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 70. Bristol-Myers Squibb Recent Developments
    Table 71. GlaxoSmithKline Company Details
    Table 72. GlaxoSmithKline Business Overview
    Table 73. GlaxoSmithKline Small Cell Lung Cancer Therapeutics Product
    Table 74. GlaxoSmithKline Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 75. GlaxoSmithKline Recent Developments
    Table 76. Menarini Company Details
    Table 77. Menarini Business Overview
    Table 78. Menarini Small Cell Lung Cancer Therapeutics Product
    Table 79. Menarini Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 80. Menarini Recent Developments
    Table 81. Ziopharm Oncology Company Details
    Table 82. Ziopharm Oncology Business Overview
    Table 83. Ziopharm Oncology Small Cell Lung Cancer Therapeutics Product
    Table 84. Ziopharm Oncology Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 85. Ziopharm Oncology Recent Developments
    Table 86. Merck Company Details
    Table 87. Merck Business Overview
    Table 88. Merck Small Cell Lung Cancer Therapeutics Product
    Table 89. Merck Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 90. Merck Recent Developments
    Table 91. Novartis Company Details
    Table 92. Novartis Business Overview
    Table 93. Novartis Small Cell Lung Cancer Therapeutics Product
    Table 94. Novartis Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 95. Novartis Recent Developments
    Table 96. AstraZeneca Company Details
    Table 97. AstraZeneca Business Overview
    Table 98. AstraZeneca Small Cell Lung Cancer Therapeutics Product
    Table 99. AstraZeneca Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 100. AstraZeneca Recent Developments
    Table 101. Takeda Pharmaceutical Company Details
    Table 102. Takeda Pharmaceutical Business Overview
    Table 103. Takeda Pharmaceutical Small Cell Lung Cancer Therapeutics Product
    Table 104. Takeda Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 105. Takeda Pharmaceutical Recent Developments
    Table 106. Teva Pharmaceutical Company Details
    Table 107. Teva Pharmaceutical Business Overview
    Table 108. Teva Pharmaceutical Small Cell Lung Cancer Therapeutics Product
    Table 109. Teva Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 110. Teva Pharmaceutical Recent Developments
    Table 111. Eli Lilly Company Details
    Table 112. Eli Lilly Business Overview
    Table 113. Eli Lilly Small Cell Lung Cancer Therapeutics Product
    Table 114. Eli Lilly Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 115. Eli Lilly Recent Developments
    Table 116. Mylan Company Details
    Table 117. Mylan Business Overview
    Table 118. Mylan Small Cell Lung Cancer Therapeutics Product
    Table 119. Mylan Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 120. Mylan Recent Developments
    Table 121. Sun Pharmaceuticals Industries Company Details
    Table 122. Sun Pharmaceuticals Industries Business Overview
    Table 123. Sun Pharmaceuticals Industries Small Cell Lung Cancer Therapeutics Product
    Table 124. Sun Pharmaceuticals Industries Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 125. Sun Pharmaceuticals Industries Recent Developments
    Table 126. Amgen Company Details
    Table 127. Amgen Business Overview
    Table 128. Amgen Small Cell Lung Cancer Therapeutics Product
    Table 129. Amgen Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 130. Amgen Recent Developments
    Table 131. Ono Pharmaceutical Company Details
    Table 132. Ono Pharmaceutical Business Overview
    Table 133. Ono Pharmaceutical Small Cell Lung Cancer Therapeutics Product
    Table 134. Ono Pharmaceutical Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 135. Ono Pharmaceutical Recent Developments
    Table 136. Shanghai Jinhe Bio-Technology Company Details
    Table 137. Shanghai Jinhe Bio-Technology Business Overview
    Table 138. Shanghai Jinhe Bio-Technology Small Cell Lung Cancer Therapeutics Product
    Table 139. Shanghai Jinhe Bio-Technology Revenue in Small Cell Lung Cancer Therapeutics Business (2017-2022) & (US$ Million)
    Table 140. Shanghai Jinhe Bio-Technology Recent Developments
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Small Cell Lung Cancer Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Biologics Features
    Figure 3. Small Molecules Features
    Figure 4. Global Small Cell Lung Cancer Therapeutics Market Share by Application: 2021 VS 2028
    Figure 5. Hospitals Case Studies
    Figure 6. Clinics Case Studies
    Figure 7. Other Case Studies
    Figure 8. Small Cell Lung Cancer Therapeutics Report Years Considered
    Figure 9. Global Small Cell Lung Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 10. Global Small Cell Lung Cancer Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Small Cell Lung Cancer Therapeutics Market Share by Region: 2021 VS 2028
    Figure 12. Global Small Cell Lung Cancer Therapeutics Market Share by Players in 2021
    Figure 13. Global Top Small Cell Lung Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Cell Lung Cancer Therapeutics as of 2021)
    Figure 14. The Top 10 and 5 Players Market Share by Small Cell Lung Cancer Therapeutics Revenue in 2021
    Figure 15. North America Small Cell Lung Cancer Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 16. North America Small Cell Lung Cancer Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 17. North America Small Cell Lung Cancer Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 18. North America Small Cell Lung Cancer Therapeutics Market Size Share by Country (2017-2028)
    Figure 19. United States Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Small Cell Lung Cancer Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 22. Europe Small Cell Lung Cancer Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 23. Europe Small Cell Lung Cancer Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 24. Europe Small Cell Lung Cancer Therapeutics Market Size Share by Country (2017-2028)
    Figure 25. Germany Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. France Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. U.K. Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Italy Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Russia Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Nordic Countries Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Small Cell Lung Cancer Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 32. Asia Pacific Small Cell Lung Cancer Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 33. Asia Pacific Small Cell Lung Cancer Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 34. Asia Pacific Small Cell Lung Cancer Therapeutics Market Size Share by Region (2017-2028)
    Figure 35. China Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Japan Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. South Korea Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Southeast Asia Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. India Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Australia Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 41. Latin America Small Cell Lung Cancer Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 42. Latin America Small Cell Lung Cancer Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 43. Latin America Small Cell Lung Cancer Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 44. Latin America Small Cell Lung Cancer Therapeutics Market Size Share by Country (2017-2028)
    Figure 45. Mexico Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Brazil Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Middle East & Africa Small Cell Lung Cancer Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 48. Middle East and Africa Small Cell Lung Cancer Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 49. Middle East and Africa Small Cell Lung Cancer Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 50. Middle East and Africa Small Cell Lung Cancer Therapeutics Market Size Share by Country (2017-2028)
    Figure 51. Turkey Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Saudi Arabia Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. UAE Small Cell Lung Cancer Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Sanofi Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2017-2022)
    Figure 55. Bristol-Myers Squibb Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2017-2022)
    Figure 56. GlaxoSmithKline Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2017-2022)
    Figure 57. Menarini Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2017-2022)
    Figure 58. Ziopharm Oncology Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2017-2022)
    Figure 59. Merck Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2017-2022)
    Figure 60. Novartis Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2017-2022)
    Figure 61. AstraZeneca Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2017-2022)
    Figure 62. Takeda Pharmaceutical Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2017-2022)
    Figure 63. Teva Pharmaceutical Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2017-2022)
    Figure 64. Eli Lilly Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2017-2022)
    Figure 65. Mylan Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2017-2022)
    Figure 66. Sun Pharmaceuticals Industries Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2017-2022)
    Figure 67. Amgen Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2017-2022)
    Figure 68. Ono Pharmaceutical Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2017-2022)
    Figure 69. Shanghai Jinhe Bio-Technology Revenue Growth Rate in Small Cell Lung Cancer Therapeutics Business (2017-2022)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed